Search for: "Association for Molecular Pathology v. Myriad Genetics, Inc." Results 21 - 40 of 186
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Feb 2016, 1:21 pm by Gene Quinn
Prometheus Laboratories, Inc. (2012); Association for Molecular Pathology v. [read post]
18 Oct 2015, 12:24 am by Mark Summerfield
IP Australia has opened a consultation on proposed changes in examination practice in light of the High Court’s ruling in D'Arcy v Myriad Genetics Inc [2015] HCA 35. [read post]
11 Mar 2015, 9:40 am by Dennis Crouch
Roche Molecular Systems, Inc., 131 S.Ct. 2188 (2011) (ownership under Bayh-Dole) Association for Molecular Pathology v. [read post]
17 Feb 2015, 6:53 pm by Gene Quinn
Ct. 1289 (2012) and Association for Molecular Pathology v. [read post]
12 Nov 2014, 8:01 am by Schachtman
” Peter Lee, “Patent Law and the Two Cultures,” 120 Yale L.J. 2, 4 (2010); see also Association for Molecular Pathology v. [read post]
31 Oct 2014, 3:33 pm by David Jensen
Ravicher (@danravicher) October 31, 2014’ “A year before the Federal Circuit’s June decision, the Supreme Court reversed the Federal Circuit in Association for Molecular Pathology v. [read post]
23 Oct 2014, 9:51 pm by Patent Docs
Myriad Genetics, Inc. (2013), and Mayo Collaborative Services v. [read post]
13 Oct 2014, 11:36 am by Gene Quinn
Supreme Court should have reached in Association of Molecular Pathology v. [read post]
30 Sep 2014, 9:59 pm by Patent Docs
Myriad Genetics, Inc. (2013), and Mayo Collaborative Services v. [read post]
7 Sep 2014, 4:34 am by Jani
Since the US Supreme Court's decision in Association of Molecular Pathology v Myriad Genetics last year (more on which can be found on this very blog here and here), most of the general public and even the legal profession thought that the matter was done and dusted, and that genes, in the application created by Myriad Genetics, would be unpatentable. [read post]
5 Sep 2014, 9:41 pm by Mark Summerfield
D'Arcy v Myriad Genetics Inc [2014] FCAFC 115 (5 September 2014)A special expanded bench of five judges of the Federal Court of Australia has thumbed its collective nose at the US Supreme Court, finding that isolated genetic material is patent-eligible in Australia, and that (‘with respect’, of course) the emphasis of the US’ top court (in Association for Molecular Pathology v Myriad… [read post]
5 Sep 2014, 9:38 am by Gene Quinn
Supreme Court should have reached in Association of Molecular Pathology v. [read post]